Agenus Inc
Change company Symbol lookup
Select an option...
AGEN Agenus Inc
RDCM Radcom Ltd
BAC Bank of America Corp
$GSPIN S&P INTERNET&CAT
LJPC La Jolla Pharmaceutical Co
NBR Nabors Industries Ltd
GPRO GoPro Inc
DDD 3D Systems Corp
AAPL Apple Inc
ARNC Arconic Inc
Go

Health Care : Biotechnology | Small Cap GrowthCompany profile

Agenus Inc. (Agenus) is an immuno-oncology (I-O) company. The Company focuses on the discovery and development of therapies that engage the body's immune system to fight cancer. It is developing a I-O portfolio driven by platforms and programs, such as antibody discovery platforms, including Retrocyte Display, SECANT yeast display and phage display technologies designed to produce human antibodies; antibody candidate programs, including checkpoint modulator (CPM) programs; vaccine programs, including Prophage, AutoSynVax and PhosPhoSynVax, and saponin-based vaccine adjuvants, principally QS-21 Stimulon adjuvant (QS-21 Stimulon). The Company's discovery pipeline includes a range of checkpoint modulating (CPM) antibodies. The Company's vaccine platforms include its heat shock protein (HSP)-based Prophage vaccine candidates, and its synthetic vaccine candidates, ASV and PSV.

Postmarket

Last Trade
Delayed
$4.19
-0.17 (-3.90%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$4.36
Day's Change
0.00 (0.00%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
4.43
Day's Low
4.22
Volume
(Above Average)
Volume:
2,700,461

10-day average volume:
2,324,772
2,700,461
  • Prev Close
    4.36
  • Today's Open
    4.34
  • Day's Range
    4.22-4.43
  • Avg Vol (10-day)
    2.3M
  • Last (time)
    4:00p ET 11/20/19
  • Last (size)
    6
  • 52-Wk Range
    1.95 - 4.57
    LowHigh
  • (12/26/18 - 11/19/19)
    4.60%
  • 67.9%
  • Market Cap
    598.9M
  • Shares Outstanding
    137.4M
  • -0.98
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 2.0
  • 34.63
  • (% of float 10/31/19)
    9.69

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.